Drug Type Vaccine |
Synonyms TG 01, TG01 |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 2 | NO | 19 May 2023 | |
Smoldering Multiple Myeloma | Phase 2 | NO | 19 May 2023 | |
Pancreatic adenocarcinoma | Phase 2 | NO | 01 Dec 2012 | |
Pancreatic adenocarcinoma | Phase 2 | ES | 01 Dec 2012 | |
Pancreatic adenocarcinoma | Phase 2 | GB | 01 Dec 2012 |
Phase 1/2 | 32 | btaeblleph(pbuppkszhs) = howkzcogxa ouuonrbgvi (ffylziiidt, qbzxatdfsk - bnjbmckmzd) View more | - | 14 May 2020 | |||
Phase 1/2 | 32 | hzrrahstgq(ikpaljxneh) = four serious adverse reactions considered possibly related to TG01 treatment, including three allergic reactions rqxpmvtufx (lethubkhcz ) View more | Positive | 01 Mar 2020 |